Literature DB >> 16632116

Up-regulation of gamma-glutamyl transpeptidase activity following glutathione depletion has a compensatory rather than an inhibitory effect on mitochondrial complex I activity: implications for Parkinson's disease.

Shankar J Chinta1, Jyothi M Kumar, Hongqiao Zhang, Henry Jay Forman, Julie K Andersen.   

Abstract

Up-regulation of activity of gamma-glutamyl transpeptidase (GGT) has been reported to occur in the Parkinsonian substantia nigra, the area of the brain affected by the disease. Increased GGT activity has been hypothesized to play a role in subsequent mitochondrial complex I (CI) inhibition by increasing cysteine as substrate for cellular uptake. Intracellular cysteine has been proposed to form toxic adducts with dopamine which can be metabolized to compounds which inhibit CI activity. We have demonstrated that in addition to CI inhibition, GGT activity is up-regulated in dopaminergic cells as a consequence of glutathione depletion. Inhibition of GGT rather than resulting in increased CI inhibition results in exacerbation of this inhibitory effect. This suggests that increased GGT activity is likely an adaptive response to the loss of glutathione to conserve intracellular glutathione content and results in a compensatory effect on CI activity rather than in its inhibition as has been previously widely hypothesized.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16632116      PMCID: PMC2804072          DOI: 10.1016/j.freeradbiomed.2005.12.023

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  23 in total

1.  Mice with genetic gamma-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility.

Authors:  C O Harding; P Williams; E Wagner; D S Chang; K Wild; R E Colwell; J A Wolff
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

2.  Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease.

Authors:  H Li; G Dryhurst
Journal:  J Neurochem       Date:  1997-10       Impact factor: 5.372

3.  Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines.

Authors:  I A Trounce; Y L Kim; A S Jun; D C Wallace
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

4.  Measurement of gamma-glutamyl transpeptidase and gamma-glutamylcysteine synthetase activities in cells.

Authors:  H J Forman; M M Shi; T Iwamoto; R M Liu; T W Robison
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  A one-step fluorometric method for the continuous measurement of monoamine oxidase activity.

Authors:  M Zhou; N Panchuk-Voloshina
Journal:  Anal Biochem       Date:  1997-11-15       Impact factor: 3.365

6.  Characterization and transplantation of two neuronal cell lines with dopaminergic properties.

Authors:  F S Adams; F G La Rosa; S Kumar; J Edwards-Prasad; S Kentroti; A Vernadakis; C R Freed; K N Prasad
Journal:  Neurochem Res       Date:  1996-05       Impact factor: 3.996

7.  Quinones increase gamma-glutamyl transpeptidase expression by multiple mechanisms in rat lung epithelial cells.

Authors:  R M Liu; M M Shi; C Giulivi; H J Forman
Journal:  Am J Physiol       Date:  1998-03

8.  Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase.

Authors:  M H Hanigan; W A Ricketts
Journal:  Biochemistry       Date:  1993-06-22       Impact factor: 3.162

9.  gamma-Glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells.

Authors:  A Kugelman; H A Choy; R Liu; M M Shi; E Gozal; H J Forman
Journal:  Am J Respir Cell Mol Biol       Date:  1994-11       Impact factor: 6.914

10.  Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease.

Authors:  F Zhang; G Dryhurst
Journal:  J Med Chem       Date:  1994-04-15       Impact factor: 7.446

View more
  16 in total

1.  Iron mediates neuritic tree collapse in mesencephalic neurons treated with 1-methyl-4-phenylpyridinium (MPP+).

Authors:  Francisco J Gómez; Pabla Aguirre; Christian Gonzalez-Billault; Marco T Núñez
Journal:  J Neural Transm (Vienna)       Date:  2010-10-02       Impact factor: 3.575

Review 2.  Glutathione and apoptosis.

Authors:  Magdalena L Circu; Tak Yee Aw
Journal:  Free Radic Res       Date:  2008-08

3.  Evaluation of markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains.

Authors:  Rajeswara Babu Mythri; C Venkateshappa; G Harish; Anita Mahadevan; Uday B Muthane; T C Yasha; M M Srinivas Bharath; S K Shankar
Journal:  Neurochem Res       Date:  2011-04-12       Impact factor: 3.996

Review 4.  S-glutathionylation: from molecular mechanisms to health outcomes.

Authors:  Ying Xiong; Joachim D Uys; Kenneth D Tew; Danyelle M Townsend
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

5.  Quantitative mapping of reversible mitochondrial Complex I cysteine oxidation in a Parkinson disease mouse model.

Authors:  Steven R Danielson; Jason M Held; May Oo; Rebeccah Riley; Bradford W Gibson; Julie K Andersen
Journal:  J Biol Chem       Date:  2011-01-01       Impact factor: 5.157

6.  GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism.

Authors:  Michelle Smeyne; Justin Boyd; Kennie Raviie Shepherd; Yun Jiao; Brooks Barnes Pond; Matthew Hatler; Roland Wolf; Colin Henderson; Richard Jay Smeyne
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

7.  1-methyl-4-phenylpyridinium-induced alterations of glutathione status in immortalized rat dopaminergic neurons.

Authors:  Derek A Drechsel; Li-Ping Liang; Manisha Patel
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-12       Impact factor: 4.219

8.  Protective effects of zonisamide against rotenone-induced neurotoxicity.

Authors:  Salvatore Condello; Monica Currò; Nadia Ferlazzo; Gregorio Costa; Giuseppa Visalli; Daniela Caccamo; Laura Rosa Pisani; Cinzia Costa; Paolo Calabresi; Riccardo Ientile; Francesco Pisani
Journal:  Neurochem Res       Date:  2013-10-20       Impact factor: 3.996

Review 9.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

10.  Coupling endoplasmic reticulum stress to the cell death program in dopaminergic cells: effect of paraquat.

Authors:  Shankar J Chinta; Anand Rane; Karen S Poksay; Dale E Bredesen; Julie K Andersen; Rammohan V Rao
Journal:  Neuromolecular Med       Date:  2008-09-05       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.